Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Regular movement and strength training support firmer muscles and better microcirculation
The Wegovy pill is a higher dose of the oral semaglutide Rybelsus (7 mg and 14 mg), FDA-approved in 2019 for treating type 2 diabetes (T2D) and in October 2025 for cardiovascular risk reduction in those with T2D at high risk
Additionally, tirzepatide was designed to bind to the GIPR with an affinity 5-fold stronger than that for the GLP1R, resulting in greater potency and selectivity in engaging the GIPR over the GLP1R
Research Models & Proposed Pathways Semaglutide primarily acts through GLP-1 receptor agonism
US$ 25.57
US$ 20.56
US$ 25.45
US$ 27.19
US$ 20.52
